Skip to main content
. 2020 Oct 15;10:17504. doi: 10.1038/s41598-020-74412-2

Table 2.

Solute transport data from 24-h collection of dialysate and urine in patients on continuous ambulatory (CAPD), continuous cyclic (CCPD), automated peritoneal dialysis (APD) and for all pooled therapies.

(1) CAPD
n = 48
(2) CCPD
n = 25
(3) APD
n = 81
All
n = 154
Dialysis time, h/day(***) 23.43 ± 2.54(3) 21.51 ± 4.15(3) 10.03 ± 0.43(1,2) 16.30 ± 6.79
Cycle, no/day(***) 3.88 ± 0.44(2,3) 5.87 ± 0.67(1,3) 4.82 ± 0.62(1,2) 4.69 ± 0.88
Infused volume, L/day(***) 8.19 ± 1.58(2,3) 12.60 ± 1.60(1,3) 10.20 ± 1.52(1,2) 9.94 ± 2.15
Drained volume, L/day(***) 9.62 ± 1.74(2,3) 14.20 ± 1.76(1,3) 11.39 ± 1.71(1,2) 11.28 ± 2.30
Ultrafiltration, L/day(***) 1.42 ± 0.50(3) 1.60 ± 0.69(3) 1.19 ± 0.44(1,2) 1.33 ± 0.53
Weekly urea KT/V
Peritoneal urea KT/V(***) 1.72 ± 0.36(3) 1.85 ± 0.26(3) 1.59 ± 0.33(1,2) 1.68 ± 0.35
Renal urea KT/V(***) 0.34 ± 0.43(2) 0.04 ± 0.10(1,3) 0.42 ± 0.54(2) 0.33 ± 0.48
Total urea KT/V(*) 2.06 ± 0.39(2) 1.89 ± 0.27(1) 2.00 ± 0.55 2.01 ± 0.47
Weekly clearance, L/week
Peritoneal creatinine clearance(***) 48.43 ± 13.83(3) 47.39 ± 10.11(3) 34.36 ± 10.79(1,2) 41.11 ± 13.60
Renal creatinine clearance(***) 24.69 ± 37.58(2) 2.95 ± 7.82(1,3) 30.03 ± 44.03(2) 23.80 ± 39.28
Total creatinine clearance(***) 73.12 ± 35.11(2,3) 50.34 ± 12.22(1) 64.39 ± 42.06(1) 64.91 ± 37.12
Peritoneal phosphate clearance(***, a) 41.50 ± 14.50(3) 36.68 ± 9.56(3) 25.42 ± 10.18(1,2) 32.53 ± 13.81
Renal phosphate clearance(***, a) 10.98 ± 14.13(2) 1.86 ± 7.63(1,3) 13.80 ± 18.40(2) 10.90 ± 16.24
Total phosphate clearance(***, a) 52.49 ± 16.42(2,3) 38.54 ± 12.34(1) 39.23 ± 19.63(1) 43.44 ± 18.64
Weekly phosphorus removal, g/week
Peritoneal phosphorus removal(***) 1.89 ± 0.73(3) 1.91 ± 0.63(3) 1.34 ± 0.62(1,2) 1.61 ± 0.72
Renal phosphorus removal(***) 0.55 ± 0.75(2) 0.11 ± 0.48(1,3) 0.67 ± 0.86(2) 0.54 ± 0.80
Total phosphorus removal(***) 2.44 ± 0.94(2,3) 2.02 ± 0.85(1) 2.01 ± 1.00(1) 2.15 ± 0.97

(***) and (*) denote p value < 0.001 and < 0.05 during multi-comparison procedure.

(a)Means significant difference versus creatinine clearance in all investigated therapies and for pooled data.

(1,2,3)Superscripts mean significant difference (p < 0.05) between the current value and the therapies listed in bracket.